Insight

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Photo taken from Nature Communications

May 11, 2024, 12:13

Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter:

“Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.

Multiple EGFR extracellular domain variants not associated with approved targeted therapies were sensitive to afatinib and dacomitinib in vitro
Two patients with glioblastoma with somatic EGFR G598V dimerization domain mutations showed responses to dacomitinib”

Read the article.
Source: Biagio Ricciuti/X
OncoDaily

Afatinib Biagio Ricciuti cancer cancer treatment Dacomitinib EGFR Mutations Extracellular Domain Variants glioblastoma Mutation Scanning OncoDaily Oncology oncology research Research Somatic Mutations targeted therapies TKI Sensitivities

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer